New data shows SOF-SKN active ingredient efficacy
- Date and time
- Announcement type
- Company Update
Show detailsHide details
- Category
- Other
- Report codes
- 11001
- Sector
- Health Care
- Industry group
- Pharmaceuticals, Biotechnology & Life Sciences
Recent NOX announcements
- New study further validates Noxopharms cancer pipeline
- Quarterly Activities/Appendix 4C Cash Flow Report
- Pre-IND meeting request with US FDA
- Sofr platform versatility shown via childbirth MRFF grant
- Fast-tracking of cancer program via novel animal model
- SOF-SKN manufacturing begins to ensure clinical trial readi